IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 32 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,000 | -40.0% | 21,700 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 21,700 | -2.8% | 0.00% | – |
| Q1 2016 | $6,000 | -45.5% | 22,336 | -29.5% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 31,700 | +46.1% | 0.00% | – |
| Q3 2015 | $9,000 | -10.0% | 21,700 | 0.0% | 0.00% | – |
| Q2 2015 | $10,000 | -9.1% | 21,700 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | +57.1% | 21,700 | +117.0% | 0.00% | – |
| Q4 2014 | $7,000 | +40.0% | 10,000 | +78.6% | 0.00% | – |
| Q3 2014 | $5,000 | -85.7% | 5,600 | -82.1% | 0.00% | – |
| Q2 2014 | $35,000 | +483.3% | 31,221 | +524.4% | 0.00% | – |
| Q1 2014 | $6,000 | -80.0% | 5,000 | -84.6% | 0.00% | – |
| Q4 2013 | $30,000 | +25.0% | 32,533 | +240.3% | 0.00% | – |
| Q3 2013 | $24,000 | -17.2% | 9,561 | -36.3% | 0.00% | – |
| Q2 2013 | $29,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|